Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers

US Tech 100

19,513.60

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers

Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.H) announced today that it has
granted, subject to regulatory approval, options to directors and officers of
the company exercisable to acquire an aggregate of 1,500,000 common shares, at a
price of $0.10 per share, expiring July 21, 2021.

Bradmer Pharmaceuticals (TSXV:BMR.H)
Historical Stock Chart
From Oct 2024 to Nov 2024